In a cohort-wide analysis, multiple genomic regions containing recurring amplifications and deletions were identified, encompassing copy number gains in genes marked as drivers in ovarian cancer such as MYC and CCNE1 (Table S4) [9,28]. This evidence concerns the gene MYC and ovarian cancer.